This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Partnering, Business Development & Licensing
search
BIO-Europe® 2018 Interviews

Galecto Biotech's CMO discusses the company's recent EUR 79m Series C financing

Posted by on 06 November 2018
Share this article

Richard Marshall, chief medical officer at Galecto Biotech, talks to Scrip mananging editor Jo Shorthouse about how a recent financing will allow the galectin modulator company to quickly push forward its product for idiopathic pulmonary fibrosis. He also discusses the company's work in the oral and ocular therapeutic areas.

Share this article

Sign up for Partnering, Business Development & Licensing email updates

keyboard_arrow_down